about
Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals.Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptorAngiotensin II-superoxide-NFκB signaling and aortic baroreceptor dysfunction in chronic heart failureANG II stimulates phospholipase D through PKCzeta activation in VSMC: implications in adhesion, spreading, and hypertrophyAngiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathwayPYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferationAngiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cellsD5 dopamine receptor regulation of phospholipase DEffect of captopril on radiation-induced TGF-β1 secretion in EA.Hy926 human umbilical vein endothelial cells.Angiotensin II inhibits the ROMK-like small conductance K channel in renal cortical collecting duct during dietary potassium restrictionRobust dynamic balance of AP-1 transcription factors in a neuronal gene regulatory networkReduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats.p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated miceDevelopmental changes in AT1 and AT2 receptor-protein expression in ratsThe impact of age-related dysregulation of the angiotensin system on mitochondrial redox balanceEssential role of Smad3 in angiotensin II-induced vascular fibrosisPeroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?Elevated angiotensin II in rat nodose ganglia primes diabetes-blunted arterial baroreflex sensitivity: involvement of NADPH oxidase-derived superoxide.Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious ratsNADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbitsLack of protein kinase C-α leads to impaired urine concentrating ability and decreased aquaporin-2 in angiotensin II-induced hypertension.Role of stimulated intrarenal angiotensinogen in hypertension.Angiotensin peptides and their pleiotropic actions.Angiotensin II (AT1) receptors and NADPH oxidase regulate Cl- current elicited by beta1 integrin stretch in rabbit ventricular myocytesReactive oxygen species signaling in vascular smooth muscle cells.Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.Kolaviron, Biflavonoid Complex from the Seed of Garcinia kola Attenuated Angiotensin II- and Lypopolysaccharide-induced Vascular Smooth Muscle Cell Proliferation and Nitric Oxide ProductionJAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulationACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.Pyk2 mediates increased adrenergic contractile responses in arteries from DOCA-salt mice - VASOACTIVE PEPTIDE SYMPOSIUM.Regulation of T-cell function by endogenously produced angiotensin II.Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant ratsAngiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1.COX-1-derived PGE2 and PGE2 type 1 receptors are vital for angiotensin II-induced formation of reactive oxygen species and Ca(2+) influx in the subfornical organOlmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7)Angiotensin II-Superoxide Signaling and Arterial Baroreceptor Function in Type-1 Diabetes MellitusToxic effects of mercury, lead and gadolinium on vascular reactivity.Local renin-angiotensin systems in the genitourinary tract.New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.
P2860
Q24812374-F2B24C8F-95BD-4B62-BBD5-4718251AB7CFQ24815241-4447EA11-F15D-4F78-BD28-DC1AE5996E03Q26777284-9FBC08F2-EA8F-4DB0-B078-96E2500CB654Q28571340-DCB93706-23CE-41BB-B8E6-940F9111FC5AQ28574928-CF340EDA-E2B7-4FFC-B5D4-24040E1303D1Q28578929-4509D009-BD20-4475-9943-4F20D32C3B40Q28582292-4D1F68FF-134B-432D-B4C8-B5B2FD61D23BQ28587661-58C83F4E-FCCC-4DBA-ADF3-BD2D0892F18CQ33591373-F7AA3F3A-EFF2-4BCE-BA0F-15C9F8BD2677Q33655455-E5BB3D63-A9BE-49BB-AFF5-3490CC59C0ADQ33774688-65A352B4-ED1D-46D6-981C-2E222560FE93Q34192179-7297C5B9-EEBD-4C30-A233-0C0D38F04EB6Q34376157-CEED95C8-E271-4AF3-BB1B-011F1EE74569Q34557839-6B39E688-A9F1-4FCE-9E3A-73E55FC361F2Q34562975-B639D886-9411-4D19-B5E6-2676DA137542Q34575283-A112E2B8-4933-4790-A0EE-78C5B2CA9AF2Q35688221-7F9BB588-9CD1-421B-8809-47AD33E610C6Q35716845-1D1ABF25-C00B-46D6-A46B-234E9D80116EQ35777568-CC2EA659-7C27-41FA-B5AB-47E47C9D18CBQ36114032-40A74564-AD23-49BA-9F4A-4F783F51B208Q36200287-F97C31AA-2273-4E0E-8CF4-1D90CF61496EQ36219052-BB7E4BC6-225B-4534-B171-3BF3260E930BQ36416940-C20B2E06-699C-42CE-87BB-D6B9CCE3BE33Q36445350-1E14986E-53CF-4D72-BD1C-967D1C62F85DQ36450264-8F284AB6-1EEC-4423-B52A-905AB4F907A6Q36755237-686FD1F4-3B42-459B-84C4-9B7D1D4EAFCBQ36766168-35AA00D2-49EC-4CF9-B697-F291240A713EQ36895449-40DE2934-E761-4466-A8C0-DE3C3DBBB11FQ36929414-BDEF461C-54BB-417B-A8E3-0E5D51A3EB03Q37071076-54297B57-5BB6-441A-82CA-48BCCD2AF192Q37100479-1CADFDCF-EE1D-4079-AEBE-9DC7AA4BA130Q37138957-3BD9E839-0946-42D5-9C44-EB199F33BC5BQ37210914-29D081B0-75F0-4760-AFF0-10DC8D68EAB8Q37247141-4BB92C3A-C88E-4CB8-93E9-70AD7CB1AE08Q37342150-7D75183A-669E-455E-9110-A4B05E693028Q37505197-902751C3-ACC1-45F6-BC54-6E28A0EC7012Q37598169-4B2EA39F-83DF-4C3D-9AEB-CC28D38ED74AQ37918430-7BD15C88-CD36-4FCB-A795-88035FA8A99EQ37955678-7C64A1D0-CFEC-4543-965D-35AC422478B2Q37982718-A40D2BF6-F585-417B-B45F-5CD85518550C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Recent advances in angiotensin II signaling.
@ast
Recent advances in angiotensin II signaling.
@en
Recent advances in angiotensin II signaling.
@nl
type
label
Recent advances in angiotensin II signaling.
@ast
Recent advances in angiotensin II signaling.
@en
Recent advances in angiotensin II signaling.
@nl
prefLabel
Recent advances in angiotensin II signaling.
@ast
Recent advances in angiotensin II signaling.
@en
Recent advances in angiotensin II signaling.
@nl
P2860
P1476
Recent advances in angiotensin II signaling.
@en
P2093
P2860
P304
P356
10.1590/S0100-879X2002000900001
P407
P577
2002-08-30T00:00:00Z